Comparison of different treatment modalities for postmenopausal patients osteopenia: Hormone replacement therapy, calcitonin and clodronate

Climacteric

Volumn 3, Issue 2, 2000, Pages 92-101

  Tiras M B ^a,b   Noyan, V ^a   Yildiz, A ^a   Biberoglu K ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Calcitonin; Clodronate; Hormone replacement therapy; Osteopenia

Indexed keywords

ALKALINE PHOSPHATASE; CALCITONIN; CALCIUM; CLODRONIC ACID; CREATININE; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; PARATHYROID HORMONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DENSITOMETRY; DIET SUPPLEMENTATION; DRUG EFFICACY; FEMALE; FEMUR NECK; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPENIA; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033856312     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.3109/13697130009167610     Document Type: Article

References (31)

1. 1. Riggs BL, Melton LJ. Clinical heterogeneity of involutional osteoporosis: implications of preventive therapy. J Clin Endocrinol Metab 1990;70:1299
2. 2. Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. N Engl J Med 1992; 327:620-7
3. 3. Gilsanz V, Roe TF, Mora S, et al. Changes in vertebral bone density in black girls and white girls during childhood and puberty. N Engl J Med 1991;325:1597-600
4. 4. Genant HK, David MD, Baylink J, Gallagher JC. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 1989;161:1842-56
5. 5. Riggs BL, Wahner HW, Dunn WL, et al. Differential changes in bone mineral density of the appendicular skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981;67: 328-35
6. 6. Melton LJ, Chrishilles EA, Cooper C, et al. How many people have osteoporosis? J Bone Miner Res 1992;7:1005-10
7. 7. Marshall D, Johnell O, Wedel H, et al. Metaanalysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 1996;312:1254-9
8. 8. Cummings SR, Black DM, Nevitt MC. Appendicular bone density and age predict hip fracture in women. J Am Med Assoc 1990;263:665-8
9. 9. Kiel DP, Felson DT, Anderson JJ, et al. Hip fracture and the use of estrogens in postmenopausal women: the Framingham study. N Engl J Med 1987;317:1169-74
10. 10. Weiss NS, Ure CL, Ballard JH, et al. Decreased risk of fractures of lower forearm with postmenopausal use of estrogen. N Engl J Med 1996;313: 1195-8
11. 11. Renzo GCD, Coata G, Cosmi EV, et al. Management of postmenopausal osteoporosis. Obstet Gynecol 1994;56:47-53
12. 12. Quigley MET, Martin PL, Burnir AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987;156: 1516-23
13. 13. Lindsay R, Hart DM, Aitken JM, et al Long-term prevention of postmenopausal osteoporosis by estrogen: evidence for an increased bone mass after delayed onset of estrogen treatment. Lancet 1976;1:1038-41
14. 14. Lindsay R, Tohme J. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 1990;76:290
15. 15. Bush TL, Wells HB, James MK, et al. Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. J Am Med Assoc 1996; 276:1389-96
16. 16. Eiken P, Pors Nielsen S, Kolthoff N, et al. Effects of bone mass after eight years of hormonal replacement therapy. Br J Obstet Gynaecol 1997; 104:702-7
17. 17. Ettinger B, Genant HK, Cann CE, et al. Long term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102: 319
18. 18. Michaelsson K, Baron JA, Farahmand BY, et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. Br Med J 1998;316:1858-63
19. 19. Horsman A, Jones M, Francis R, Nordin B. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med 1983;309:1405-7
20. 20. Speroff L, Rowan J, Symons J, et al. The comparative effect of bone density, endometrium and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. J Am Med Assoc 1996;276: 1397-403
21. 21. Munk-Jensen N, Pors S, Obel EB, Eriksen PB. Reversal of postmenopausal vertebral bone loss by estrogen and progestagen: a double blind placebo controlled study. Br Med J 1988;296: 1150-2
22. 22. Gallagher JC, Kable WT, Goldgar D, et al. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med 1991;90:171-8
23. 23. Garnero P, Sornay RE, Chapuy MC, et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337-49
24. 24. Giannini S, D'Angelo L, Malvasi L, et al. Effects of one year cyclical treatment with clodronate on postmenopausal bone loss. Bone 1993;14: 137-41
25. 25. Fillipponi P, Cristallini S, Rizzello E, et al. Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long term clinical trial. Bone 1996;18:179-84
26. 26. Fillipponi P, Pedetti M, Fedeli L, et al. Cyclical clodronate is effective in preventing postmenopausal bone loss: a comparative study with transcutaneous hormone replacement therapy. J Bone Miner Res 1995;10:697-703
27. 27. Ellerington MC, Hillard TC, Whitcroft SI, et al. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis. Calcif Tissue Int 1996;59:6-11
28. 28. Arnala L, Saastamomen J, Alhava M. Salmon calcitonin in the prevention of bone loss at perimenopause. Bone 1996;4:629-32
29. 29. Overgaard K. Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose response study. Calcif Tissue Int 1994;55:82-6
30. 30. Kollerup G, Hermann AP, Brixen K, et al. Effect of salmon calcitonin suppositories on bone mass and turnover in established osteoporosis. Calcif Tissue Int 1994;54:12-15
31. 31. Macedo JM, Macedo CR, Elkis H, De Oliveria IR. Meta-analysis about efficacy of anti-resorptive drugs in postmenopausal osteoporosis. J Clin Pharm Ther 1998;23:345-52